Patent barriers to medicine access in South Africa: A case for patent law reform

by Catherine Tomlinson, Yuan Qiong Hu, Julia Hill et al.
Publication of the Fix the Patent Laws Campaign, September 2016

56 pp. 2.6 MB
http://www.msfaccess.org/sites/default/files/ACCES_report_FTPL_ENG_2016.pdfpic-006_resize

The new report presents nine case studies that illustrate how millions of patients suffer the consequence of a flawed patent registration system allows pharmaceutical companies to prolong their patent monopoly periods in South Africa for years (and sometimes even decades) after patent protections have expired elsewhere in the world. People are suffering and dying because medicines for cancer, hepatitis, tuberculosis, mental health disorders and many other diseases are too expensive. Without reforms, many medicines in South Africa will remain unaffordable or unavailable.

(Visited 20 times, 1 visits today)
This entry was posted in Essential Medicines, General. Bookmark the permalink.